Subjects: CCA, FVT
Penumbra, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
ALAMEDA, Calif., July 19, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 38th Annual Growth Conference in Boston, MA on Wednesday, August 8, 2018.
|
Event: |
Canaccord Genuity 38th Annual Growth Conference |
|
Date: |
Wednesday, August 8, 2018 |
|
Time: |
10:00am ET / 7:00am PT |
A webcast of the presentation will be available by visiting the investors section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets medical devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs. Penumbra sells its products to hospitals primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra P logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com.
Investor Relations
Penumbra, Inc.
510-995-2461
[email protected]
SOURCE Penumbra, Inc.
These press releases may also interest you
|
News published on and distributed by:
